随访门诊中重症监护后综合征的中期特征:COVID-19与非COVID-19幸存者的前瞻性比较
该单中心前瞻性观察研究纳入ICU停留≥7天且参加出院3个月(M3)随访门诊的成人幸存者143例(COVID-19组86例、非COVID-19组57例),采用标准化量表评估健康相关生活质量、睡眠、躯体功能、心理健康与认知。两组M3结局总体相似,仅COVID组PSQI更高(6 [3-9.5] vs 4 [2-7],p=0.038)、非COVID组Barthel指数略低(100 [100-100] vs 100 [85-100],p=0.026),但各评分异常比例两组相似。143例中仅58例(40.6%)三项指标(MoCA≥26、IES-R<33、Barthel=100)均正常,68.5%(98/143)未恢复基线日常活动水平。作者认为,无论COVID-19还是其他危重症,主要PICS域异常比例相似,认知与睡眠是最受累的两个域。
要点
- ICU出院3个月时,COVID-19与非COVID-19幸存者各PICS评分异常比例相似,仅COVID组PSQI更高(6 [3-9.5] vs 4 [2-7],p=0.038)。
- 非COVID组Barthel指数略低于COVID组(100 [100-100] vs 100 [85-100],p=0.026),但异常比例两组相似。
- 143例中仅58例(40.6%)MoCA≥26、IES-R<33且Barthel=100三项均正常。
- 68.5%(98/143)在M3未恢复基线日常活动水平。
- COVID组ICU停留更长(18 d [10.8-30 d] vs 10 d [8-17.2 d],p=0.001),但M3主要PICS域异常比例仍与非COVID组相似。
适用人群与场景
- ICU停留≥7天且参加出院3个月随访门诊的成人幸存者;COVID-19急性呼吸窘迫综合征幸存者86例,非COVID-19危重症幸存者57例。
诊断标准与关键阈值
- 认知正常定义为MoCA≥26分;创伤后应激正常定义为IES-R<33分;躯体功能正常定义为Barthel指数=100分。
研究设计与关键结果
- 单中心前瞻性观察研究,纳入143例ICU幸存者(COVID-19组86例、非COVID-19组57例),在ICU出院3个月(M3)随访门诊进行标准化评估。
- 两组中位年龄与严重程度评分相似;非COVID组ICU停留短于COVID组(10 d [8-17.2 d] vs 18 d [10.8-30 d],p=0.001)。
- M3时两组结局相似,仅COVID组PSQI更高(6 [3-9.5] vs 4 [2-7],p=0.038)、非COVID组Barthel指数略低(100 [100-100] vs 100 [85-100],p=0.026);各评分异常比例两组相似。
- 健康相关生活质量两组相似。
- 143例中58例(40.6%)MoCA≥26、IES-R<33且Barthel=100三项均正常;68.5%(98/143)未恢复基线日常活动水平。
- 认知与睡眠是受累最突出的两个PICS域。
证据类型、等级与局限
- 证据类型:单中心前瞻性观察研究。
- 局限:原文未报告局限性。
对床旁实践的改变
- 作者认为,COVID-19与其他危重症幸存者出院3个月时主要PICS域异常比例相似,尽管COVID组ICU停留更长。
- 作者指出,认知与睡眠是受累最突出的两个PICS域,随访评估应关注这两方面。
提炼说明
- 本条依据论文摘要整理;摘要未涉及「处置流程与药物剂量」「红旗征与不能漏的情况」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开
UNLABELLED: At present, it is not clear if critically ill COVID-19 survivors have different needs in terms of follow-up compared with other critically ill survivors, and thus if duplicated post-ICU trajectories are mandatory.
OBJECTIVES: To compare the post-intensive care syndrome (PICS) of COVID-19 acute respiratory distress syndrome and non-COVID-19 (NC) survivors referred to a follow-up clinic at 3 months (M3) after ICU discharge.
DESIGN SETTING AND PARTICIPANTS: Adults who survived an ICU stay greater than or equal to 7 days and attended the M3 consultation were included in this observational study performed in a post-ICU follow-up clinic of a single tertiary hospital.
MAIN OUTCOMES AND MEASURES: Patients underwent a standardized assessment, addressing health-related quality of life (3-level version of EQ-5D), sleep disorders (Pittsburgh Sleep Quality Index [PSQI]), physical status (Barthel index, handgrip and quadriceps strengths), mental health disorders (Hospital Anxiety and Depression Scale and Impact of Event Scale-Revised [IES-R]), and cognitive impairment (Montreal Cognitive Assessment [MoCA]).
RESULTS: A total of 143 survivors (86 COVID and 57 NC) attended the M3 consultation. Their median age and severity scores were similar. NC patients had a shorter ICU stay (10 d [8-17.2 d]) compared with COVID group (18 d [10.8-30 d]) (p = 0.001). M3 outcomes were similar in the two groups, except for a higher PSQI (p = 0.038) in the COVID group (6 [3-9.5]) versus NC group (4 [2-7]), and a slightly lower Barthel index in the NC group (100 [100-100]) than in the COVID group (100 [85-100]) (p = 0.026). However, the proportion of patients with abnormal values at each score was similar in the two groups. Health-related quality of life was similar in the two groups. The three MoCA (≥ 26), IES-R (<33), and Barthel (=100) were normal in 58 of 143 patients (40.6%). In contrast, 68.5% (98/143) had not returned to their baseline level of daily activities.
CONCLUSIONS AND RELEVANCE: In our follow-up clinic at 3 months after discharge, the proportion of patients presenting alterations in the main PICS domains was similar whether they survived a COVID-19 or another critical illness, despite longer ICU stay in COVID group. Cognition and sleep were the two most affected PICS domains.
参考来源
- Rousseau AF, Colson C, Minguet P, et al. Characteristics of Mid-Term Post-Intensive Care Syndrome in Patients Attending a Follow-Up Clinic: A Prospective Comparison Between COVID-19 and Non-COVID-19 Survivors. Crit Care Explor. 2023. PMID: 36699242. doi:10.1097/CCE.0000000000000850
供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。